Finding the Tail End: the Discovery of RNA Splicing PROFILE Melissa Suran, Science Writer

Total Page:16

File Type:pdf, Size:1020Kb

Finding the Tail End: the Discovery of RNA Splicing PROFILE Melissa Suran, Science Writer PROFILE Finding the tail end: The discovery of RNA splicing PROFILE Melissa Suran, Science Writer Major findings are sometimes hidden in small details. Molecular biologists at the time worked almost At least that was the case when, in a PNAS article, exclusively with bacterial systems, which are easy to molecular biologist Phillip Sharp and his research grow in a laboratory. Although Sharp primarily studied team described a little strand of RNA that led to an bacteria and published work about the Escherichia coli understanding of how proteins are synthesized in genome during his postdoctoral position at the cells (1). California Institute of Technology with biochemist During the 1970s, Sharp headed a laboratory in the Norman Davidson (2, 3), he started exploring tumor Center for Cancer Research at the Massachusetts biology and virology. When Sharp arrived at CSHL, he turned his attention toward DNA viruses known to in- Institute of Technology (MIT). Having been a post- fect animal cells. He was particularly curious about doctoral researcher for geneticist James Watson and gene expression—the conversion of DNA into instruc- then a staff member at Cold Spring Harbor Laboratory tions for creating proteins—in human cells and began (CSHL) prior to his appointment at MIT, Sharp was studying the transcriptional profile of a simian DNA drawn to studying genes and measuring chromosome virus called SV40. Found in both humans and mon- sizes. The field of genetics was relatively primitive; keys, SV40 can generate tumors. Sharp’s work with Watson and Francis Crick had discovered DNA’s struc- the virus stemmed from a collaboration with virolo- ture only 2 decades earlier. gist Joseph Sambrook. Meanwhile, an officemate, Ulf Fig. 1. Members of the MIT Center for Cancer Research (Robert Weinberg, Second Row from Bottom, Far Left; Susan Berget, Third Row from Bottom, Third from Left; Claire Moore, Back Row, Fourth from Left; Philip Sharp, Back Row, Far Right). Image courtesy of Robert Weinberg. Published under the PNAS license. See Classic Article “Spliced segments at the 5′ terminus of adenovirus 2 late mRNA” on page 3171 in issue 8 of volume 74. www.pnas.org/cgi/doi/10.1073/pnas.1919416116 PNAS Latest Articles | 1of4 Downloaded by guest on September 26, 2021 Fig. 2. (A–C) Electron micrograph of a hexon mRNA hybridized to an adenovirus genome fragment. The arrows in the micrographs mark the single-stranded RNA tails at the ends of the RNA/DNA hybrid. The 5’ to 3’ orientation of the mRNA is indicated in C, and the displaced single-stranded viral DNA is shown as a thin line. Reproduced with permission from ref. 1. Pettersson, worked on DNA replication of adenovirus, a member of the Whitehead Institute for Biomedical a common virus with a double-stranded DNA genome Research and professor of biology at MIT. that is known to cause tumors in rodents and a range In fact, Weinberg adds, not all groups at the center of illnesses in humans. focused directly on cancer as a disease. “The MIT “Ulf and I became friends,” Sharp says. “He was cancer center was built on the notion that curiosity- interested in adenovirus DNA replication; I was interested driven research is likely to yield great benefits.” in adenovirus transcriptional activities and the location And it did. During the 1970s and 1980s, MIT’s of genes.” Center for Cancer Research was a research powerhouse A few years earlier, microbiologists Daniel Nathans with notable scientists, including David Baltimore and and Hamilton Smith discovered enzymes called re- Susumu Tonegawa, who won Nobel Prizes for discov- striction endonucleases (4–6), which earned them a ering reverse transcriptase and the rearrangement of shared Nobel Prize with Werner Arber. Following their antibody genes, respectively. insights, Sharp developed a method to purify restriction Around 1975, Weinberg organized a weekly meeting for the center’s fifth floor laboratories to discuss their re- enzymes using gel electrophoresis and ethidium bro- search. Little did Sharp know that those meetings would mide staining. Eventually, Sharp, Pettersson, and others ultimately play an integral role in a landmark discovery. made restriction maps of the adenovirus 2 and 5 ge- In 1976, postdoctoral fellow Susan Berget began nomes as well as several other serotypes. These maps using electron microscopy to examine the relationship were used to identify the viral regions that contained between cytoplasmic RNA and the DNA structure of cancer-causing genes. adenovirus. Both Sharp and Berget worked closely “The transcriptional pattern was important for un- with Claire Moore, a technician who ran MIT’s electron derstanding how the virus created tumors,” Sharp microscopy facility for the cancer center. Through her says. “It also set the table for a long-term curiosity: work with Sharp, Moore became familiar with a tech- ” The significance of heterogeneous nuclear RNA. nique called R-loop analysis, which at the time was a ’ When Sharp was recruited by MIT s cancer center, new method to map RNA sequences on a genome. By he and postdoctoral fellow Jane Flint extended the creating optimal conditions using a combination of ’ transcriptional maps of adenovirus. One of Sharp s salt, formamide, and heat, Moore could make an colleagues, molecular biologist Robert Weinberg, RNA strand hybridize with its complementary DNA. ran an adjacent laboratory on the fifth floor and stud- “You would see a bit of string, and there would be ied SV40. Both adenovirus and SV40 can produce a bubble where the RNA had hybridized with the DNA multiple copies of their genomes in infected cells, and displaced the other strand,” says Moore, now a enabling analysis. professor of developmental, molecular, and chemical “The reason that Phil Sharp, and I, and others biology at Tufts University. “Phil thought that would worked on DNA tumor viruses, like adenovirus and be a great way to map the adenovirus because you SV40, was actually not because we were interested could precisely map the location of each gene.” in cancer per se, but because these viruses clone their Adenovirus replicates efficiently, so when Berget own genomes for us,” says Weinberg, who is currently infected a human cell line, the majority of the messenger 2of4 | www.pnas.org/cgi/doi/10.1073/pnas.1919416116 Suran Downloaded by guest on September 26, 2021 RNA (mRNA) molecules would be of viral origin; as its name suggests, mRNA serves as an intermediary tem- plate, transmitting information from DNA to proteins. Berget purified the most abundant viral mRNAs, which encode a capsid protein, and in collaboration with Moore, subjected the mRNAs to hybridization condi- tions in order to form R-loops with specific re- striction endonuclease fragments of the adenovirus genome. The resulting R-loops were visualized using electron microscopy, and the length of the R-loops and double-stranded DNA were measured to de- termine the gene’s location. “My task was to prepare the samples,” Moore says. “There were a lot of tricks to getting a good spread.” With a viscous solution of formamide and a ramp constructed from a slide that ran into another solution, Moore had to drop a sample on the slide at just the right place so it would spread onto a film. Once Berget and Moore collected the film on a tiny grid coated with plastic, they processed it for electron microscopy. This film was subsequently inserted into the electron microscope and examined for interpretable R-loop structures that were then photographed. To get accu- rate measurements, the micrographs were photograph- ically printed, and a “little map measurer,” as Moore puts it, was traced along each strand. Throughout this process for dozens of micrographs, something seemed off. “I was getting nice, uniform R-loops, but there were these little strands of single-stranded RNA stick- ing out at the ends of the R-loops, and I didn’t know what to do with them,” Moore says. Other laboratories had previously found that ade- novirus RNA in the nucleus was far longer than cytoplasmic mRNA. The team wondered if these long, viral RNAs were related to observations of cellular heterogeneous nuclear RNAs. Similar to adenovirus RNAs, these nuclear RNAs containing gene sequences were considerably longer than more stable mRNAs in Fig. 3. (A) Phillip Sharp receives the 1993 Nobel Prize in Physiology or Medicine the cell cytoplasm. from King Carl XVI Gustaf of Sweden. Image courtesy of Tobbe Gustavsson/ Berget, Moore, and Sharp concluded that one of Reportagebild/TT/Sipa USA. (B) Richard Roberts receives the 1993 Nobel Prize in the extensions must be a polyadenosine tail that is Physiology or Medicine from King Carl XVI Gustaf of Sweden. Image courtesy of AGIP/Rue des Archives/Granger, NYC. added posttranscriptionally to the end of mRNA and has nothing with which to hybridize. Assuming that the other tail was an artifact, possibly caused by DNA But 3 months and several experiments later, the rehybridizing and displacing RNA, the team con- extra tail was still a mystery. ducted a myriad of experiments. They eliminated “It was a puzzle until Sue presented the data at one the opposite DNA strand so nothing could compete of the floor meetings, and we got the idea that maybe with the end of the RNA. However, when the RNA it’s coming from a different region of the adenovirus,” hybridized to a single-stranded bit of DNA, the tail was Moore says. still present. Even trying different conditions of form- So the team tried hybridizing the RNA to a longer amide and salt proved unsuccessful. Nevertheless, piece of DNA. Sharp and his colleagues were determined to rule out “That’s when the little tail found its partner strands other explanations for the tail before proceeding.
Recommended publications
  • Download Issue
    Cell Circuitry || Science Teaches English || The Chicken Genome Is Hot || Magnets in Medicine SEPTEMBER 2002 www.hhmi.org/bulletin Leading Doublea Life It’s a stretch, but doctors who work bench to bedside say they wouldn’t do it any other way. FEATURES 14 On Human Terms 24 The Evolutionary War A small—some say too small—group of Efforts to undermine evolution education have physician-scientists believes the best science evolved into a 21st-century marketing cam- requires patient contact. paign that relies on legal acumen, manipulation By Marlene Cimons of scientific literature and grassroots tactics. 20 Engineering the Cell By Trisha Gura Adam Arkin sees the cell as a mechanical system. He hopes to transform molecular 28 Call of the Wild biology into a kind of cellular engineering Could quirky, new animal models help scien- and in the process, learn how to move cells tists learn how to regenerate human limbs or from sickness to health. avert the debilitating effects of a stroke? By M. Mitchell Waldrop By Kathryn Brown 24 In front of a crowd of 1,500, Ohio’s Board of Education heard testimony on whether students should learn about intelligent design in science class. DEPARTMENTS 2 NOTA BENE 33 PERSPECTIVE ulletin Intelligent Design Is a Cop-Out 4 LETTERS September 2002 || Volume 15 Number 3 NEWS AND NOTES HHMI TRUSTEES PRESIDENT’S LETTER 5 JAMES A. BAKER, III, ESQ. 34 Senior Partner, Baker & Botts A Creative Influence In from the Fields ALEXANDER G. BEARN, M.D. Executive Officer, American Philosophical Society 35 Lost on the Tip of the Tongue Adjunct Professor, The Rockefeller University UP FRONT Professor Emeritus of Medicine, Cornell University Medical College 36 Biology by Numbers FRANK WILLIAM GAY 6 Follow the Songbird Former President and Chief Executive Officer, SUMMA Corporation JAMES H.
    [Show full text]
  • Nobel Laureates Endorse Joe Biden
    Nobel Laureates endorse Joe Biden 81 American Nobel Laureates in Physics, Chemistry, and Medicine have signed this letter to express their support for former Vice President Joe Biden in the 2020 election for President of the United States. At no time in our nation’s history has there been a greater need for our leaders to appreciate the value of science in formulating public policy. During his long record of public service, Joe Biden has consistently demonstrated his willingness to listen to experts, his understanding of the value of international collaboration in research, and his respect for the contribution that immigrants make to the intellectual life of our country. As American citizens and as scientists, we wholeheartedly endorse Joe Biden for President. Name Category Prize Year Peter Agre Chemistry 2003 Sidney Altman Chemistry 1989 Frances H. Arnold Chemistry 2018 Paul Berg Chemistry 1980 Thomas R. Cech Chemistry 1989 Martin Chalfie Chemistry 2008 Elias James Corey Chemistry 1990 Joachim Frank Chemistry 2017 Walter Gilbert Chemistry 1980 John B. Goodenough Chemistry 2019 Alan Heeger Chemistry 2000 Dudley R. Herschbach Chemistry 1986 Roald Hoffmann Chemistry 1981 Brian K. Kobilka Chemistry 2012 Roger D. Kornberg Chemistry 2006 Robert J. Lefkowitz Chemistry 2012 Roderick MacKinnon Chemistry 2003 Paul L. Modrich Chemistry 2015 William E. Moerner Chemistry 2014 Mario J. Molina Chemistry 1995 Richard R. Schrock Chemistry 2005 K. Barry Sharpless Chemistry 2001 Sir James Fraser Stoddart Chemistry 2016 M. Stanley Whittingham Chemistry 2019 James P. Allison Medicine 2018 Richard Axel Medicine 2004 David Baltimore Medicine 1975 J. Michael Bishop Medicine 1989 Elizabeth H. Blackburn Medicine 2009 Michael S.
    [Show full text]
  • 2004 Albert Lasker Nomination Form
    albert and mary lasker foundation 110 East 42nd Street Suite 1300 New York, ny 10017 November 3, 2003 tel 212 286-0222 fax 212 286-0924 Greetings: www.laskerfoundation.org james w. fordyce On behalf of the Albert and Mary Lasker Foundation, I invite you to submit a nomination Chairman neen hunt, ed.d. for the 2004 Albert Lasker Medical Research Awards. President mrs. anne b. fordyce The Awards will be offered in three categories: Basic Medical Research, Clinical Medical Vice President Research, and Special Achievement in Medical Science. This is the 59th year of these christopher w. brody Treasurer awards. Since the program was first established in 1944, 68 Lasker Laureates have later w. michael brown Secretary won Nobel Prizes. Additional information on previous Lasker Laureates can be found jordan u. gutterman, m.d. online at our web site http://www.laskerfoundation.org. Representative Albert Lasker Medical Research Awards Program Nominations that have been made in previous years may be updated and resubmitted in purnell w. choppin, m.d. accordance with the instructions on page 2 of this nomination booklet. daniel e. koshland, jr., ph.d. mrs. william mccormick blair, jr. the honorable mark o. hatfied Nominations should be received by the Foundation no later than February 2, 2004. Directors Emeritus A distinguished panel of jurors will select the scientists to be honored. The 2004 Albert Lasker Medical Research Awards will be presented at a luncheon ceremony given by the Foundation in New York City on Friday, October 1, 2004. Sincerely, Joseph L. Goldstein, M.D. Chairman, Awards Jury Albert Lasker Medical Research Awards ALBERT LASKER MEDICAL2004 RESEARCH AWARDS PURPOSE AND DESCRIPTION OF THE AWARDS The major purpose of these Awards is to recognize and honor individuals who have made signifi- cant contributions in basic or clinical research in diseases that are the main cause of death and disability.
    [Show full text]
  • Download Ps Nobel Prizes for Site BEE 11.18.16 Revised 11.30.17.Pdf
    Nobel Laureates at the College of Physicians and Surgeons For years, College of Physicians and Surgeons alumni, faculty, and researchers have led groundbreaking clinical and basic scientific studies that have transformed our understanding of human biology and advanced the practice of medicine. On many occasions, this work has been honored with the Nobel Prize. The scope of research led by P&S Nobel laureates is tremendous. Although most of our prizewinners were honored for work in physiology or medicine, a few also received the prize for chemistry. Their research has fundamentally shaped the course of numerous fields, including cardiology, neuroscience, genetics, pharmaceutical development, and more. Our Nobel laureates include: André Cournand and Dickinson Richards (P&S’23), whose work at P&S on cardiac catheterization—a method of inserting a tiny tube into the heart—provided the basis for open-heart surgery and interventional cardiology Baruch Blumberg (P&S’51), who discovered the hepatitis B virus and helped develop a test and a vaccine for the virus Joshua Lederberg, a Columbia College and P&S graduate student who showed that bacteria can exchange genes when they reproduce, creating a way to model and study genetics in higher organisms Harold Varmus (P&S’66), who demonstrated how genes in normal human and animal cells can mutate to cause cancer, leading to a new generation of research on the genetic origins of cancer Eric Kandel, current University Professor, who showed how memories are stored in nerve cells, greatly enhancing
    [Show full text]
  • February 5, 2010, NIH Record, Vol. LXII, No. 3
    FEBRUARY 5, 2010 The Second Best Thing About Payday VOL. LXII, NO. 3 The Revolution Continues Green Offers Tour of Genomic Landscape, Circa 2010 By Rich McManus ABOVE · NIAID’s Alonda LeCounte sacrificed a kidney to benefit her stepfather. See story here is a good reason that Lipsett on p. 7. TAmphitheater was jammed with at- features tendees as NHGRI began its modestly titled Current Topics in Genome Analysis 1 course—an institute staple since 1995— Green Presents Challenges of Genomic Medicine on Jan. 12. The 11-lecture series that ends Mar. 23 was launched by NHGRI di- 3 rector Dr. Eric Green, who in 90 minutes Greider Explains Science Behind Her Nobel Prize surveyed highlights of what mankind has learned of its genetic heritage start- 5 ing before Mendel (1865) to the present. Harvard’s Frenk Lectures on Global Health A postdoctoral fellow at the outset of the Human Genome Project in 1990, NHGRI director Dr. Eric Green 7 Green offered a robust primer of a field NIAID Employee’s Generosity Offers that literally exploded during the “genomic revolution” of the 1990s. Having a front- Stepfather New Life row seat at what is arguably the most significant scientific endeavor of the past century 12 gives Green both authority and a rich fund of metaphor: the 3 billion base pairs NHGRI Fellow Plays with ‘Rock Stars see genome, page 6 Of Science’ Anything Is Possible Nobelist Nirenberg, MIT’s Herr Works to Discoverer of the Make Physical Genetic Code, departments Disabilities a Thing Mourned Of the Past By Alan Schechter Briefs 2 By Valerie Lambros Milestones 9 Dr.
    [Show full text]
  • Biographical Notes on Scientists Involved in the Asilomar Process M.J
    International Dimensions of Ethics Education in Science and Engineering Case Study Series: Asilomar Conference on Laboratory Precautions Appendix D: Biographical Notes on Scientists involved in the Asilomar Process M.J. Peterson Version 1, June 2010 Edward A. Adelberg (1920-2009). PhD Yale 1949. Chair of Yale Department of Microbiology 1961-64 and 1970-72; a founding member of Yale Department of Genetics. Deputy Provost for the Biomedical Sciences, 1983-91. Specialist in plasmid biochemistry of E. coli. Ephraim Anderson (1911-2006). M.D., Durham University. Served in the Royal Army Medical Corps during World War II where he developed interests in Epidemiology. Researcher in Enteric Laboratory of the British Public Health Laboratory Service 1947, Deputy Director 1952, Director 1954-1978. Came to public notice for tracing sources of typhoid outbreaks in Zermatt (1963) and Aberdeen (1964). Built on earlier work by Japanese researchers to demonstrate the plasmid-based pathways by which bacteria could spread antibiotic resistance to others and became the world’s leading expert on antibiotic resistance. Also prominent in efforts to limit use of antibiotics in raising animals. Fellow of the Royal Society 1968; Companion of the Order of the British Empire 1976. Eric Ashby, Baron Ashby (1904-1992). Lecturer in Botany, Imperial College London 1931-35; Reader in Botany Bristol University 1935-37; Professor of Botany University of Sydney 1938-1946; Chair of Botany, University of Manchester 1947-50. Turned to administration as President and Vice-Chancellor of Queen's University, Belfast 1950-59; Master of Clare College in Cambridge University 1959-67 and Vice-Chancellor of Cambridge University 1967-1969.
    [Show full text]
  • Balcomk41251.Pdf (558.9Kb)
    Copyright by Karen Suzanne Balcom 2005 The Dissertation Committee for Karen Suzanne Balcom Certifies that this is the approved version of the following dissertation: Discovery and Information Use Patterns of Nobel Laureates in Physiology or Medicine Committee: E. Glynn Harmon, Supervisor Julie Hallmark Billie Grace Herring James D. Legler Brooke E. Sheldon Discovery and Information Use Patterns of Nobel Laureates in Physiology or Medicine by Karen Suzanne Balcom, B.A., M.L.S. Dissertation Presented to the Faculty of the Graduate School of The University of Texas at Austin in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy The University of Texas at Austin August, 2005 Dedication I dedicate this dissertation to my first teachers: my father, George Sheldon Balcom, who passed away before this task was begun, and to my mother, Marian Dyer Balcom, who passed away before it was completed. I also dedicate it to my dissertation committee members: Drs. Billie Grace Herring, Brooke Sheldon, Julie Hallmark and to my supervisor, Dr. Glynn Harmon. They were all teachers, mentors, and friends who lifted me up when I was down. Acknowledgements I would first like to thank my committee: Julie Hallmark, Billie Grace Herring, Jim Legler, M.D., Brooke E. Sheldon, and Glynn Harmon for their encouragement, patience and support during the nine years that this investigation was a work in progress. I could not have had a better committee. They are my enduring friends and I hope I prove worthy of the faith they have always showed in me. I am grateful to Dr.
    [Show full text]
  • Members of Groups Central to the Scientists' Debates About Rdna
    International Dimensions of Ethics Education in Science and Engineering Case Study Series: Asilomar Conference on Laboratory Precautions Appendix C: Members of Groups Central to the Scientists’ Debates about rDNA Research 1973-76 M.J. Peterson Version 1, June 2010 Signers of Singer-Söll Letter 1973 Maxine Singer Dieter Söll Signers of Berg Letter 1974 Paul Berg David Baltimore Herbert Boyer Stanley Cohen Ronald Davis David S. Hogness Daniel Nathans Richard O. Roblin III James Watson Sherman Weissman Norton D. Zinder Organizing Committee for the Asilomar Conference David Baltimore Paul Berg Sydney Brenner Richard O. Roblin III Maxine Singer This case was created by the International Dimensions of Ethics Education in Science and Engineering (IDEESE) Project at the University of Massachusetts Amherst with support from the National Science Foundation under grant number 0734887. Any opinions, findings, conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. More information about the IDEESE and copies of its modules can be found at http://www.umass.edu/sts/ethics. This case should be cited as: M.J. Peterson. 2010. “Asilomar Conference on Laboratory Precautions When Conducting Recombinant DNA Research.” International Dimensions of Ethics Education in Science and Engineering. Available www.umass.edu/sts/ethics. © 2010 IDEESE Project Appendix C Working Groups for the Asilomar Conference Plasmids Richard Novick (Chair) Royston C. Clowes (Institute for Molecular Biology, University of Texas at Dallas) Stanley N. Cohen Roy Curtiss III Stanley Falkow Eukaryotes Donald Brown (Chair) Sydney Brenner Robert H. Burris (Department of Biochemistry, University of Wisconsin) Dana Carroll (Department of Embryology, Carnegie Institution, Baltimore) Ronald W.
    [Show full text]
  • Restriction Enzymes and the Boon to Modern Molecular Biology
    PNAS CLASSIC PAPER Danna and Nathans: Restriction enzymes and the boon to modern molecular biology n 1971, a paper published in PNAS proteins and viral RNA. Although he time,’’ said Danna, currently an associ- (1) helped jump-start the era of never obtained a Ph.D., the work gave ate professor at the University of Colo- modern molecular biology and bio- him confidence and experience with bio- rado (Boulder). ‘‘You would try hard to technology, eventually giving rise to chemistry, leading to a faculty position solve a problem and then go to him if Imany of the genetic advances that seem so in the microbiology department at The you needed help.’’ commonplace today. The article, written Johns Hopkins University School of by Academy member Daniel Nathans and Medicine (Baltimore) in 1962. In A Clear Vision his then graduate student, Kathleen Nathans’ own words, he became ‘‘a one- Smith and his postdoctoral student Kelly Danna, exposed the marvelous utility of man ‘Division of Genetics’ ’’ (3), which made rapid progress with their indepen- restriction enzymes. In the accompanying gradually morphed into a sizable group, dent study of the Hemophilus influenzae Perspective highlighting this classic work including graduate student Kathleen restriction enzyme, concluding in 1970 of scientific literature, Rich Roberts pro- Danna, fellow professor Hamilton O. that the enzyme cleaved DNA only at vides a historical account of the scientific Smith, and Smith’s postdoctoral student sites with a specific arrangement of base discoveries leading up to the PNAS paper Thomas Kelly. This combination of tal- pairs. However, after publishing their and the unparalleled scientific advances ents would prove highly fruitful in the findings (4), the scientists abandoned made after its publication.
    [Show full text]
  • Timeline of Immunology
    TIMELINE OF IMMUNOLOGY 1549 – The earliest account of inoculation of smallpox (variolation) occurs in Wan Quan's (1499–1582) 1718 – Smallpox inoculation in Ottoman Empire realized by West. Lady Mary Wortley Montagu, the wife of the British ambassador to Constantinople, observed the positive effects of variolation on the native population and had the technique performed on her own children. 1796 – First demonstration of smallpox vaccination (Edward Jenner) 1837 – Description of the role of microbes in putrefaction and fermentation (Theodore Schwann) 1838 – Confirmation of the role of yeast in fermentation of sugar to alcohol (Charles Cagniard-Latour) 1840 – Proposal of the germ theory of disease (Jakob Henle) 1850 – Demonstration of the contagious nature of puerperal fever (childbed fever) (Ignaz Semmelweis) 1857–1870 – Confirmation of the role of microbes in fermentation (Louis Pasteur) 1862 – Phagocytosis (Ernst Haeckel) 1867 – Aseptic practice in surgery using carbolic acid (Joseph Lister) 1876 – Demonstration that microbes can cause disease-anthrax (Robert Koch) 1877 – Mast cells (Paul Ehrlich) 1878 – Confirmation and popularization of the germ theory of disease (Louis Pasteur) 1880 – 1881 -Theory that bacterial virulence could be attenuated by culture in vitro and used as vaccines. Proposed that live attenuated microbes produced immunity by depleting host of vital trace nutrients. Used to make chicken cholera and anthrax "vaccines" (Louis Pasteur) 1883 – 1905 – Cellular theory of immunity via phagocytosis by macrophages and microphages (polymorhonuclear leukocytes) (Elie Metchnikoff) 1885 – Introduction of concept of a "therapeutic vaccination". Report of a live "attenuated" vaccine for rabies (Louis Pasteur and Pierre Paul Émile Roux). 1888 – Identification of bacterial toxins (diphtheria bacillus) (Pierre Roux and Alexandre Yersin) 1888 – Bactericidal action of blood (George Nuttall) 1890 – Demonstration of antibody activity against diphtheria and tetanus toxins.
    [Show full text]
  • Daniel Nathans 1928–1999
    NATIONAL ACADEMY OF SCIENCES DANIEL NATHANS 1928–1999 A Biographical Memoir by DANIEL DIMAIO Any opinions expressed in this memoir are those of the author and do not necessarily reflect the views of the National Academy of Sciences. Biographical Memoirs, VOLUME 79 PUBLISHED 2001 BY THE NATIONAL ACADEMY PRESS WASHINGTON, D.C. Photo by Arthur Kravetz, Baltimore, Maryland DANIEL NATHANS October 30, 1928–November 16, 1999 BY DANIEL DIMAIO ANIEL NATHANS, A SCIENTIST whose pioneering use of D restriction endonucleases revolutionized virology and genetics and whose personal qualities had a profound impact on those who knew him, passed away in November 1999 at the age of 71. He was the University Professor of Molecular Biology and Genetics at the Johns Hopkins University School of Medicine, where he served on the faculty for 37 years, and a senior investigator of the Howard Hughes Medical Institute since 1982. Dan is survived by his wife, Joanne; three sons, Eli, Jeremy, and Benjamin; and seven grand- children. Dan was born and raised in Wilmington, Delaware, the youngest of eight children of Russian Jewish immigrants. He attended the University of Delaware, initially living at home and commuting by hitchhiking, and graduated with a degree in chemistry in 1950. He then entered medical school at Washington University in St. Louis, largely because, he claimed, his father saw him “as the last chance to have a doctor in the family.” Dan began medical school with the intention of returning to Wilmington as a general practitioner, but a summer job in a local hospital bored him and made him rethink these plans and return early to St.
    [Show full text]
  • Lasker Interactive Research Nom'18.Indd
    THE 2018 LASKER MEDICAL RESEARCH AWARDS Nomination Packet albert and mary lasker foundation November 1, 2017 Greetings: On behalf of the Albert and Mary Lasker Foundation, I invite you to submit a nomination for the 2018 Lasker Medical Research Awards. Since 1945, the Lasker Awards have recognized the contributions of scientists, physicians, and public citizens who have made major advances in the understanding, diagnosis, treatment, cure, and prevention of disease. The Medical Research Awards will be offered in three categories in 2018: Basic Research, Clinical Research, and Special Achievement. The Lasker Foundation seeks nominations of outstanding scientists; nominations of women and minorities are encouraged. Nominations that have been made in previous years are not automatically reconsidered. Please see the Nomination Requirements section of this booklet for instructions on updating and resubmitting a nomination. The Foundation accepts electronic submissions. For information on submitting an electronic nomination, please visit www.laskerfoundation.org. Lasker Awards often presage future recognition of the Nobel committee, and they have become known popularly as “America’s Nobels.” Eighty-seven Lasker laureates have received the Nobel Prize, including 40 in the last three decades. Additional information on the Awards Program and on Lasker laureates can be found on our website, www.laskerfoundation.org. A distinguished panel of jurors will select the scientists to be honored with Lasker Medical Research Awards. The 2018 Awards will
    [Show full text]